Correction (DOI:10.1016/j.jstrokecerebrovasdis.2008.11.001);Keep the Three Hour TPA Window: The Lost Study of Atlantis

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 1, 2009, Pages 78-79

  Clark, Wayne M ^a   Madden, Kenneth P ^b  

^a Oregon Stroke Center   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CITICOLINE; DISUFENTON SODIUM;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; DISEASE SEVERITY; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 57749169501     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.02.001     Document Type: Erratum

References (9)

1. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., and Toni D. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359 13 (2008 Sep 25) 1317-1329
2. Clark W., Wissman S., Albers G., Jhamandas J., Madden K., and Hamilton S. The ATLANTIS study: recombinant tissue plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. A randomized, double-blind, placebo-controlled trial. JAMA 282 (1999) 2019-2026
3. Marler J.R., Tilley B.C., Lu M., et al. Early stroke treatment associated with better outcome. The NINDS rt-PA stroke study. Neurology 55 (2000) 1649-1655
4. Katzan I.L., Furlan A.J., Lloyd L.E., Frank J.I., Harper D.L., Hinchey J.A., Hammel J.P., Qu A., and Sila C.A. Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke The Cleveland Area Experience. JAMA 283 (2000) 1151-1158
5. Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice A Meta-Analysis of Safety Data Glenn D. Graham, MD PhD Stroke 2003;34:1-11.
6. *. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. Neurology 53 (1999) 424
7. Buchan A.M., Barber P.A., Newcommon N., Karbalai H., Demchuk A.M., Hoyte K.M., et al. Effectiveness of tPA in acute ischemic stroke: Outcome relates to appropriateness. Neurology 54 (2000) 679-684
8. Lopez-Ynez A., Bruno A., Williams L., Yilmaz E., Zurru C., and Biller J. Protocol violations in community-based rtPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 32 (2001) 12-16
9. Davalos A., Castillo J., Clark W., et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33 12 (2002 Dec) 2850-2857